UNSPSC 51453204: Phthalylsulfacetamide

This classification denotes a sulfonamide anti-infective agent with the molecular formula C16H14N2O6S, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 24PUW23GRX, chemically known as phthalanilic acid, 4-(acetylsulfamoyl)- but more generally known as phthalylsulfacetamide, which bears U.S. National Institutes of Health Compound Identifier 8574. The European Medicines Agency schedules Phthalylsulfacetamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB35390.

SMILES: S(=O)(=O)(NC(=O)C)C1CCC(NC(=O)C2C(CCCC2)C(=O)O)CC1.

UNSPSC 51453204 Phthalylsulfacetamide, a Commodity code, shows no aligned recent state and local procurement activity. The four recent opportunities posted under this code — Seminole County's naloxone and drug deactivation systems procurement, Texas HHS's direct-to-manufacturer prescription RFI, the City of Tampa's medical and first aid supplies bid, and MMCAP's generic pharmaceuticals RFP — all involve pharmaceutical procurement at a policy, distribution, or medical-supply level rather than the specific active pharmaceutical ingredient (phthalylsulfacetamide) the code nominally describes. The mismatch suggests that state and local procurement systems are tagging these health-related opportunities broadly without precision to individual drug substances or that the code itself has seen mission creep in practice.

The opportunities that do appear under this code span state health agencies, counties, cities, and cooperative purchasing alliances across Florida, Texas, Minnesota, and Oregon. Issuing bodies include Seminole County (direct naloxone procurement), the Texas Health and Human Services Commission (pharmacy program policy), the City of Tampa Fire Department (emergency medical supplies via IFB), and MMCAP (multistate pharmaceutical contracting). However, none of these solicitations target phthalylsulfacetamide specifically. Without recent opportunities actively procuring this pharmaceutical ingredient at the state or local level, the code presents minimal business development signal for suppliers of this product. Practitioners should verify whether state and local demand for phthalylsulfacetamide exists outside the tagged opportunities or consider whether state procurement offices are miscoding broader pharmaceutical and medical-supply buys under this commodity classification.